List of Caribou Biosciences patents

Patents where

Current Assignee

Name

Caribou Biosciences

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9580727 Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides	Patent 9580727 was granted and assigned to Caribou Biosciences on February, 2017 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9580727	February 28, 2017
‌ US Patent 9745600 Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides	Patent 9745600 was granted and assigned to Caribou Biosciences on August, 2017 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9745600	August 29, 2017
‌ US Patent 9970026 Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides	Patent 9970026 was granted and assigned to Caribou Biosciences on May, 2018 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9970026	May 15, 2018
‌ US Patent 9970027 Compositions and methods of engineered CRISPR-CAS9 systems using split-nexus CAS9-associated polynucleotides	Patent 9970027 was granted and assigned to Caribou Biosciences on May, 2018 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9970027	May 15, 2018
‌ US Patent 10227576 Engineered cascade components and cascade complexes	Patent 10227576 was granted and assigned to Caribou Biosciences on March, 2019 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	10227576	March 12, 2019
‌ US Patent 9885026 Modified cascade ribonucleoproteins and uses thereof	Patent 9885026 was granted and assigned to Caribou Biosciences on February, 2018 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9885026	February 6, 2018
‌ US Patent 9816093 Engineered nucleic acid-targeting nucleic acids	Patent 9816093 was granted and assigned to Caribou Biosciences on November, 2017 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9816093	November 14, 2017
‌ US Patent 9260752 Compositions and methods of nucleic acid-targeting nucleic acids	Patent 9260752 was granted and assigned to Caribou Biosciences on February, 2016 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9260752	February 16, 2016
‌ US Patent 11555181 Engineered cascade components and cascade complexes	Patent 11555181 was granted and assigned to Caribou Biosciences on January, 2023 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	11555181	January 17, 2023
‌ US Patent 11505808 Engineered nucleic acid-targeting nucleic acids	Patent 11505808 was granted and assigned to Caribou Biosciences on November, 2022 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	11505808	November 22, 2022
‌ US Patent 9970029 Engineered nucleic acid-targeting nucleic acids	Patent 9970029 was granted and assigned to Caribou Biosciences on May, 2018 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9970029	May 15, 2018
‌ US Patent 9771600 Engineered nucleic acid-targeting nucleic acids	Patent 9771600 was granted and assigned to Caribou Biosciences on September, 2017 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9771600	September 26, 2017
‌ US Patent 10100333 Engineered nucleic acid-targeting nucleic acids	Patent 10100333 was granted and assigned to Caribou Biosciences on October, 2018 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	10100333	October 16, 2018
‌ US Patent 10329547 Engineered cascade components and cascade complexes	Patent 10329547 was granted and assigned to Caribou Biosciences on June, 2019 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	10329547	June 25, 2019
‌ US Patent 11459588 Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides		Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	11459588	October 4, 2022
‌ US Patent 9677090 Engineered nucleic-acid targeting nucleic acids	Patent 9677090 was granted and assigned to Caribou Biosciences on June, 2017 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9677090	June 13, 2017
‌ US Patent 9745562 Methods of using engineered nucleic-acid targeting nucleic acids	Patent 9745562 was granted and assigned to Caribou Biosciences on August, 2017 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9745562	August 29, 2017
‌ US Patent 10125361 Compositions and methods of nucleic acid-targeting nucleic acids	Patent 10125361 was granted and assigned to Caribou Biosciences on November, 2018 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	10125361	November 13, 2018
‌ US Patent 10196619 Engineered nucleic-acid targeting nucleic acids	Patent 10196619 was granted and assigned to Caribou Biosciences on February, 2019 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	10196619	February 5, 2019
‌ US Patent 10138472 Engineered nucleic-acid targeting nucleic acids	Patent 10138472 was granted and assigned to Caribou Biosciences on November, 2018 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	10138472	November 27, 2018
‌ US Patent 10125354 Engineered nucleic-acid targeting nucleic acids	Patent 10125354 was granted and assigned to Caribou Biosciences on November, 2018 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	10125354	November 13, 2018
‌ US Patent 9957490 Cells comprising engineered nucleic-acid targeting nucleic acids	Patent 9957490 was granted and assigned to Caribou Biosciences on May, 2018 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9957490	May 1, 2018
‌ US Patent 9816081 Engineered nucleic-acid targeting nucleic acids	Patent 9816081 was granted and assigned to Caribou Biosciences on November, 2017 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9816081	November 14, 2017
‌ US Patent 10023853 Engineered nucleic-acid targeting nucleic acids	Patent 10023853 was granted and assigned to Caribou Biosciences on July, 2018 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	10023853	July 17, 2018
‌ US Patent 9970030 Methods for increasing CAS9-mediated engineering efficiency	Patent 9970030 was granted and assigned to Caribou Biosciences on May, 2018 by the United States Patent and Trademark Office.	Caribou Biosciences	Caribou Biosciences	United States Patent and Trademark Office	9970030	May 15, 2018

Results per page:

53 results

0 selected

53 results

0 selected